British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory ...

More than 190,000 people still sought medical help for acute respiratory infection (ARI), including 30,000 with ...

While the ‘official’ flu season may still be a month or two away, reports indicate a rise in respiratory illnesses like the ...

The authors assessed the patient characteristics associated with RSV vaccination among older adults hospitalized during the ...

The second infection was also tied to a 50% or greater increase in several specific long-COVID conditions, including ...

Older adults and people with certain medical conditions are more likely to receive the respiratory syncytial virus (RSV) ...

South Australian families will now have better protection against a potentially deadly respiratory virus, under a free state ...

Pleurisy is an inflammation of the lining of the lungs. When inflamed, the tissue layers rub against each other, causing ...

Children aged 6 months to 12 years are the main spreaders of respiratory syncytial virus (RSV) infections within their ...

A new brief report published in the American Journal of Infection Control (AJIC) demonstrates that ActivePure’s Advanced Photohydrolysis (AP) Technology effectively and rapidly inactivates aerosolized ...

The pipeline features several drugs, which are being investigated across different phases of development; 60% of the drug candidates are designed to be administered via intramuscular routes. Presently ...